Predictive biomarkers of response to cancer therapeutics
Thursday 25 March 2010
Venue: The Royal Society of Medicine, 1 Wimpole Street, London, W1G 0AE
A joint meeting with British Association of Cancer Research (BACR)
There will be opportunities to submit abstracts for short talks and poster presentations. For submissions details please contact bacr@icr.ac.uk
Registration Details:
Meeting ref: OCA05
9.30 am |
Registration with tea and coffee |
10.00 am |
Welcome address |
| Anne Thomas, Leicester Royal Infirmary, UK | |
10.05 am |
Biomarkers in targeted therapeutic development and implementation |
| Peter Parker, Cancer Research UK, London Research Institute | |
|
Session I - Predictive Biomarkers |
|
| Chair: Andy Hall, University of Newcastle upon Tyne, UK | |
10.35 am |
Apoptosis and cell signalling biomarkers |
| Caroline Dive, University of Manchester, UK | |
11.15 am |
Gene profiling biomarkers |
| Kenneth Hilan, Genentech, San Francisco, USA | |
11.55 am |
Biomarker challenges posed by chemoprevention |
| Karen Brown, University of Leicester, UK | |
12.35 pm |
Discussion |
1.00 pm |
Lunch and Poster Viewing |
|
Session II - Pharmacological and surrogate response biomarkers |
|
| Chair: Andy Gescher, University of Leicester, UK | |
2.00 pm |
Biomarker development associated with a new drug |
| Herbie Newell, University of Newcastle upon Tyne, UK | |
2.40 pm |
Predicting minimal residual disease in leukaemia |
| Julie Irving, University of Newcastle upon Tyne, UK | |
3.20 pm |
Clinical correlates for response biomarkers |
| Malcolm Ranson, Christie Hospital , Manchester, UK | |
4.00 pm |
Discussion |
4.25 pm |
Completion of Evaluation Forms |
4.30 pm |
Tea and close of meeting |
The BACR website can be found at www.bacr.org.uk.
Non BACR members can register here.
